Avina Vongpradith’s research while affiliated with University of Washington and other places

What is this page?


This page lists works of an author who doesn't have a ResearchGate profile or hasn't added the works to their profile yet. It is automatically generated from public (personal) data to further our legitimate goal of comprehensive and accurate scientific recordkeeping. If you are this author and want this page removed, please let us know.

Publications (53)


mmc3.pdf
  • Data
  • File available

February 2025

·

40 Reads

Sarah Brooke Sirota

·

Matthew C. Doxey

·

Regina-Mae Villanueva Dominguez

·

[...]

·

Hmwe Hmwe Kyu

Download




Figure 1: URI and otitis media incidence rates (A) and DALY rates (B) per 100 000 population, by super-region, in 1990 and 2021 Shaded areas are 95% uncertainty intervals. DALY=disability-adjusted life-year. URI=upper respiratory infection.
Figure 2: Global URI episodes in millions (A) and incidence rates per 100 000 population (B), by age, in 1990 and 2021 URI=upper respiratory infection.
Figure 3: Global otitis media episodes in millions (A) and incidence rates per 100 000 population (B), by age, in 1990 and 2021
Figure 4: Combined YLD rates of URIs and otitis media globally, by age, in 2021 URIs=upper respiratory infections. YLD=years lived with disability.
Global, regional, and national burden of upper respiratory infections and otitis media, 1990-2021: a systematic analysis from the Global Burden of Disease Study 2021

January 2025

·

2,012 Reads

·

6 Citations

The Lancet Infectious Diseases

Background Upper respiratory infections (URIs) are the leading cause of acute disease incidence worldwide and contribute to a substantial health-care burden. Although acute otitis media is a common complication of URIs, the combined global burden of URIs and otitis media has not been studied comprehensively. We used results from the Global Burden of Diseases, Injuries, and Risk Factors Study 2021 to explore the fatal and non-fatal burden of the two diseases across all age groups, including a granular analysis of children younger than 5 years, in 204 countries and territories from 1990 to 2021.







Citations (31)


... The number of victims of diarrheal infections points to the magnitude of this public health problem. Predictors of the quality of individual treatment by medical health care include the cost, beliefs, and the severity of strain on the health of adults who make individual treatment decisions [11,12]. ...

Reference:

The Impact of Traditional Healers on Health Outcomes for Diarrheal Diseases
Global, regional, and national age-sex-specific burden of diarrhoeal diseases, their risk factors, and aetiologies, 1990-2021, for 204 countries and territories: a systematic analysis for the Global Burden of Disease Study 2021

The Lancet Infectious Diseases

... Larynx cancer continues to be a major global public health concern, with significant disparities in mortality trends across regions and countries [25,26]. This study provides a detailed analysis of larynx cancer mortality from 1990 to 2021 using data from the GBD 2021, revealing critical insights into the patterns and determinants of this disease. ...

The burden of diseases, injuries, and risk factors by state in the USA, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021

The Lancet

... A landmark trial published in 2024 demonstrated the efficacy of the HIV-1 capsid inhibitor lenacapavir, administered twice a year by subcutaneous injection, in preventing HIV acquisition among women and girls in South Africa and Uganda. (2) This long-acting drug offers a new tool for HIV prevention, but its success depends on affordability and accessibility for those at greatest risk. The sustainability of HIV prevention and treatment programs is threatened by funding challenges. ...

Global, regional, and national burden of HIV/AIDS, 1990–2021, and forecasts to 2050, for 204 countries and territories: the Global Burden of Disease Study 2021

... Through combined political, social, and economic efforts, substantial progress was made, but nevertheless only a few countries met these targets by 2020. Thus, in 2021, a new global strategy with a focus on inequalities was proposed by UNAIDS with the aim of reducing new HIV infections from 1.65 million to less than 370,000 per year and AIDS-related deaths from 718,000 to less than 250,000 per year [2,3]. The three interim targets from the 2015 strategy were raised to 95% diagnosed, 95% treated, and 95% suppressed. ...

Global, regional, and national burden of HIV/AIDS, 1990-2021, and forecasts to 2050, for 204 countries and territories: the Global Burden of Disease Study 2021

The Lancet HIV

... Respiratory tract infections form most of the common illnesses in younger populations and are usually difficult to differentiate between viral and bacterial. 134,148,149 Hence, antibiotics are mostly prescribed empirically. This may have a catastrophic impact on the future of antimicrobial medicines and their efficacy. ...

Global, regional, and national burden of upper respiratory infections and otitis media, 1990-2021: a systematic analysis from the Global Burden of Disease Study 2021

The Lancet Infectious Diseases

... Respiratory diseases are among the most common health issues affecting children worldwide, contributing significantly to morbidity and healthcare costs (1,2). While conventional treatments such as antibiotics and bronchodilators are widely used, their overuse has raised concerns about antibiotic resistance and adverse side effects. ...

Global, regional, and national burden of upper respiratory infections and otitis media, 1990-2021: a systematic analysis from the Global Burden of Disease Study 2021

The Lancet Infectious Diseases

... org/ gbd-resul ts-tool), managed by the Institute for Health Metrics and Evaluation. This tool offers annual frequencies and age-standardized rates (ASRs) for IBD incidence, prevalence, and DALYs, categorized by sex, age, and state [20,21]. ...

Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021

The Lancet

... In 2019, an estimated 309 million disability-adjusted life-years (DALYs) were linked to 85 different parasites in children under the age of five, with Plasmodium spp., the causative agent of malaria, accounting for 12.0% of the total [186]. Another parasite, Toxoplasma gondii, is associated with various infections including congenital toxoplasmosis, which is transmitted from the mother to the foetus. ...

Global burden associated with 85 pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019
  • Citing Article
  • April 2024

The Lancet Infectious Diseases

... Our findings indicate that the burden of aLRTD remains substantial. While COVID-19 significantly impacted aLRTD incidence rates, particularly in the initial years of the pandemic, non-COVID infections remained consistent The estimates compare to a retrospective analysis of 2018-19 hospitalisations, showing an annual incidence of aLRTD of 1901 per 100,000 adults, pneumonia 591/100,000 and NP-LRTI 739/100,000 13 and also aligns with pre-pandemic estimates from other countries 14,15 . However, the 638/100,000 pneumonia incidence observed here (2020-24) was higher than Nottingham's 96.3/100,000 (2013-18) 16 . ...

Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990-2021: a systematic analysis from the Global Burden of Disease Study 2021

The Lancet Infectious Diseases

... Detailed information on data sources, processing methods, and completeness assessments can be found in Appendix 1, Section 3.5 of the GBD study. 10 The population attributable fraction was defined as the proportion of diseases or deaths that could be prevented by reducing exposure to a specific risk factor to its theoretical minimum level within a given population. Attributable deaths for LC and COPD were calculated by multiplying the population attributable fraction by the corresponding outcome quantity for each demographic group, including age, sex, location, and year. ...

Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

The Lancet